Sandesh Mahatme
2014
In 2014, Sandesh Mahatme earned a total compensation of $2.2M as Executive Vice President, Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,865 |
|---|---|
| Option Awards | $1,522,805 |
| Salary | $443,722 |
| Other | $65,637 |
| Total | $2,183,029 |
Mahatme received $1.5M in option awards, accounting for 70% of the total pay in 2014.
Mahatme also received $150.9K in non-equity incentive plan, $443.7K in salary and $65.6K in other compensation.
Rankings
In 2014, Sandesh Mahatme's compensation ranked 4,176th out of 13,032 executives tracked by ExecPay. In other words, Mahatme earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,176 out of 13,032 | 68th |
Division Manufacturing | 1,476 out of 4,966 | 70th |
Major group Chemicals And Allied Products | 479 out of 1,686 | 72nd |
Industry group Drugs | 370 out of 1,365 | 73rd |
Industry Pharmaceutical Preparations | 295 out of 1,043 | 72nd |
Source: SEC filing on April 27, 2017.
Mahatme's colleagues
We found five more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2014.
2014
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2014
Arthur Krieg
Sarepta Therapeutics
Chief Scientific Officer
2014
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2014
David Howton
Sarepta Therapeutics
General Counsel
2014
Jayant Aphale
Sarepta Therapeutics